A comparative study of two routinely used protocols for ex vivo erythroid differentiation

Blood Cells Mol Dis. 2024 May:106:102829. doi: 10.1016/j.bcmd.2024.102829. Epub 2024 Jan 23.

Abstract

Background: Erythropoiesis is a complex developmental process in which a hematopoietic stem cell undergoes serial divisions and differentiates through well-defined stages to give rise to red blood cells. Over the last decades, several protocols have been developed to perform ex vivo erythroid differentiation, allowing investigation into erythropoiesis and red cell production in health and disease.

Results: In the current study, we compared the two commonly used protocols by assessing the differentiation kinetics, synchronisation, and cellular yield, using molecular and cellular approaches. Peripheral blood CD34+ cells were cultured in a two-phase (2P) or a four-phase (4P) liquid culture (LC) and monitored for 20 days. Both protocols could recapitulate all stages of erythropoiesis and generate reticulocytes, although to different extents. Higher proliferation and viability rates were achieved in the 4P-LC, with a higher degree of terminal differentiation and enucleation, associated with higher levels of the erythroid-specific transcription factors GATA-1, KLF-1, and TAL-1. Although the 2P-LC protocol was less efficient regarding terminal erythroid differentiation and maturation, it showed a higher yield of erythroid progenitors in the erythropoietin (EPO)-free expansion phase.

Conclusions: We provide data supporting the use of one protocol or the other to study the biological processes occurring in the early or late stages of erythroid differentiation, depending on the physiological process or pathological defect under investigation in a given study.

Keywords: Erythroblasts; Ex vivo erythropoiesis; Red blood cells; Reticulocytes.

MeSH terms

  • Antigens, CD34
  • Cell Differentiation
  • Erythrocytes
  • Erythroid Precursor Cells
  • Erythropoiesis / physiology
  • Erythropoietin*
  • Hematopoietic Stem Cells*
  • Humans

Substances

  • Antigens, CD34
  • Erythropoietin